Bültmann & Gerriets
Medical Statistics for Cancer Studies
von Trevor F Cox
Verlag: CRC Press
Reihe: Chapman & Hall/CRC Biostatistics Series
Gebundene Ausgabe
ISBN: 978-0-367-48615-0
Erschienen am 23.06.2022
Sprache: Englisch
Format: 234 mm [H] x 156 mm [B] x 19 mm [T]
Gewicht: 644 Gramm
Umfang: 334 Seiten

Preis: 117,50 €
keine Versandkosten (Inland)


Jetzt bestellen und voraussichtlich ab dem 24. Oktober in der Buchhandlung abholen.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Biografische Anmerkung
Inhaltsverzeichnis

This textbook shows how cancer data can be analysed in a variety of ways, covering cancer clinical trial data, epidemiological data, biological data, and genetic data. It provides detailed overviews of survival analysis, clinical trials, regression analysis, epidemiology, meta-analysis, biomarkers, and cancer informatics.



Trevor F. Cox is retired from Liverpool Cancer Trials Unit, University of Liverpool, UK



1 Introduction. 1.1. About Cancer. 1.2. Cancer studies. 1.3. R Code. 2. Cancer Biology and Genetics for Non-Biologists. 2.1. Cells. 2.2. DNA, Genes, RNA and Proteins. 2.3. Cancer - DNA Gone Wrong. 2.4. Cancer Treatments. 2.5. Measuring Cancer in the Patient. 3. Survival Analysis. 3.1. The Amazing Survival Equations. 3.2. Non-parametric Estimation of Survival Curves. 3.3. Fitting Parametric Survival Curves to Data. 3.4. Comparing Two Survival Distributions. 3.5. The ESPAC4-Trial. 3.6. Comparing Two Parametric Survival Curves. 4. Designing and Running a Clinical Trial. 4.1. Types of Trials and Studies. 4.2. Clinical Trials. 5. Regression Analysis for Survival Data. 5.1. A Weibull Parametric Regression Model. 5.2. Cox Proportional Hazards Model. 5.3. Accelerated Failure Time (AFT) Models. 5.4. Proportional Odds Models. 5.5. Parametric Survival Distributions for PH and AFT Models. 5.6. Flexible Parametric Models. 6. Clinical Trials: The Statistician's Role. 6.1. Sample Size Calculation. 6.2. Examples of Sample Size Calculations; Phases I to III. 6.3. Group Sequential Designs. 6.4. More Statistical Tasks for Clinical Trials. 7. Cancer Epidemiology. 7.1. Measuring Cancer. 7.2. Cancer Statistics for Countries. 7.3. Cohort Studies. 7.4. Case-control Studies. 7.5. Cross-sectional Studies. 7.6. Spatial Epidemiology. 8. Meta-Analysis. 8.1. How to Carry Out a Systematic Review. 8.2. Fixed Effects Model. 8.3. Random Effects Model. 8.4. Bayesian Meta-analysis. 8.5. Network Meta-analysis. 8.6. Individual Patient Data. 9. Cancer Biomarkers. 9.1. Diagnostic Biomarkers. 9.2. Prognostic Biomarkers. 9.3. Predictive Biomarkers for Pancreatic Cancer. 9.4. Biomarker Trial Design. 10. Cancer Informatics. 10.1. Producing Genetic Data. 10.2. Analysis of Microarray Data. 10.3. Pre-processing NGS Data. 10.4. TCGA-KIRC: Renal Clear Cell Carcinoma.


andere Formate
weitere Titel der Reihe